Globalpharma’s sales in the Saudi pharmaceutical market surged by 139.5% year-over-year in May 2024, reaching $12.6M up from $5.2M in 2023 Dubai, UAE, 27 August 2024: Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, today announced a significant milestone by capturing a 1.8% market share in the competitive … Continue reading GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia